Marshall Wace, LLP Blueprint Medicines Corp Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 333,767 shares of BPMC stock, worth $31.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

333,767

Previous 351,756 5.11%

Holding current value

$31.5 Million

Previous $37.9 Million 18.6%

% of portfolio

0.04%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$84.1 - $120.5 $1.51 Million - $2.17 Million	-17,989 Reduced 5.11%	333,767 $30.9 Million
Q2 2024 Aug 14, 2024	BUY	$85.18 - $108.78 $10.3 Million - $13.2 Million	121,464 Added 52.74%	351,756 $37.9 Million
Q1 2024 May 15, 2024	BUY	$73.17 - $99.79 $16.9 Million - $23 Million	230,292 New	230,292 $21.8 Million
Q4 2022 Feb 14, 2023	BUY	$41.06 - $66.48 $21.7 Million - $35.2 Million	529,456 New	529,456 $23.2 Million
Q2 2022 Aug 15, 2022	SELL	$45.23 - $70.15 $8.44 Million - $13.1 Million	-186,600 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$54.1 - $110.08 $41.3 Million - $84.1 Million	-764,082 Reduced 80.37%	186,600 $11.9 Million
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $87 Million - $107 Million	923,577 Added 3407.4%	950,682 $102 Million
Q3 2021 Nov 15, 2021	SELL	$80.98 - $109.47 $970,221 - $1.31 Million	-11,981 Reduced 30.65%	27,105 $2.79 Million
Q2 2021 Aug 13, 2021	BUY	$82.78 - $101.0 $3.24 Million - $3.95 Million	39,086 New	39,086 $3.44 Million
Q1 2021 May 17, 2021	SELL	$90.71 - $108.28 $330,365 - $394,355	-3,642 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$92.08 - $124.48 $23.7 Million - $32 Million	-257,260 Reduced 98.6%	3,642 $408,000
Q3 2020 Nov 16, 2020	BUY	$66.45 - $92.7 $15.8 Million - $22.1 Million	238,042 Added 1041.3%	260,902 $24.2 Million
Q2 2020 Aug 13, 2020	SELL	$57.09 - $79.27 $10.7 Million - $14.9 Million	-188,146 Reduced 89.17%	22,860 $1.78 Million
Q1 2020 May 15, 2020	BUY	$48.11 - $82.22 $9.82 Million - $16.8 Million	204,103 Added 2956.73%	211,006 $12.3 Million
Q4 2019 Feb 14, 2020	BUY	$66.73 - $82.59 $460,637 - $570,118	6,903 New	6,903 $553,000
Q1 2019 May 14, 2019	SELL	$48.7 - $86.6 $420,524 - $747,791	-8,635 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$45.57 - $74.26 $6.37 Million - $10.4 Million	-139,699 Reduced 94.18%	8,635 $466,000
Q3 2018 Nov 14, 2018	BUY	$58.91 - $78.32 $8.74 Million - $11.6 Million	148,334 New	148,334 $11.6 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.64B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Blueprint Medicines Corp Transaction History